Navigation Links
Psoriasis Cure Now Welcomes Institute of Medicine Report Urging 'Comparative Effectiveness' Research on Psoriasis, But Worries About Risk of Rationing
Date:6/30/2009

KENSINGTON, Md., June 30 /PRNewswire-USNewswire/ -- "Psoriasis Cure Now," a nonprofit patient advocacy group, today applauded the Institute of Medicine (IOM) for including psoriasis and psoriatic arthritis among its Top 100 health topics meriting priority "comparative effectiveness" research, but the organization expressed concern that treatment rationing could result from the research.

The IOM included the use of biologics for treating inflammatory diseases including psoriatic arthritis among its top ("First Quartile") priorities for the first round of comparative effectiveness research, and included comparing the effectiveness of various treatments for psoriasis among its Second Quartile priorities. According to the IOM, "A committee convened by the IOM developed the list of priority topics at the request of Congress as part of a $1.1 billion effort to improve the quality and efficiency of health care through comparative effectiveness research outlined in the American Recovery and Reinvestment Act of 2009."

"We applaud the IOM committee for including treatments for psoriasis and psoriatic arthritis among its priority research areas, as it can be very challenging for patients with these lifelong diseases to navigate their myriad treatment options, each of which has its own set of short and long-term risks," said Michael Paranzino, president of Psoriasis Cure Now. "But as with most things in life, the devil is in the details. Comparative effectiveness research requires assigning extremely controversial dollar amounts to various levels of patient improvement, and also assigns monetary values to various levels of risk of side-effects, even though a 25 year-old mother and a 70 year-old man might have very different levels of willingness to risk serious side-effects. Today's comparative effectiveness research can very easily become tomorrow's rationing mandate."

Paranzino continued, "Different psoriasis treatments vary widely in cost, effectiveness, and side-effects. Some patients will trade less effectiveness for fewer side-effects. Others will accept serious long-term risks to feel better now. In addition, some psoriasis treatments cause catastrophic birth defects if given to women who become pregnant while taking them, but help men without these risks. In short, for a researcher to conclude that Treatment A helps an 'average' patient improve for less money than Treatment B, that researcher must make assumptions that may fly in the face of reality for real patients in real-world circumstances.

"It is essential that patient voices be heard throughout the actual comparative effectiveness research, or else this could become just a fancy way to deny advanced, but costly, treatments to people with serious but incurable diseases like psoriasis."

For more information on psoriasis, visit the Psoriasis Cure Now homepage at http://www.psoriasis-cure-now.org.


'/>"/>
SOURCE Psoriasis Cure Now
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Source of Information on Psoriasis Medications
2. Psoriasis Raises Risk of Heart Attack, Stroke, Death
3. American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications
4. Psoriasis Patients Happy With Home-Based Treatment
5. Study Results Published in CUTIS Demonstrate Long-Term Safety and Efficacy of Vectical(TM) (calcitriol) Ointment 3 mcg/g in the Management of Mild-to-Moderate Plaque Psoriasis
6. Having Psoriasis Raises Risk of Diabetes, Hypertension
7. Psoriasis Drug Raptiva Pulled From U.S. Market
8. Low-Dose Acitretin May Reduce Nail Psoriasis
9. BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis
10. LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nations Capital
11. Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Arkansas that offers insurance and financial preparation services, is providing an update on ... Rescue organization. , Rock City Rescue is a locally recognized nonprofit that provides ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
Breaking Medicine Technology: